Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2023

Genmab — Marts 2023

Planlagt Fastgjort Låst Flyttet Genmab
499 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    peter12
    wrote on sidst redigeret af
    #410

    Jeg spurgte chatgpt om bnt322. Tror ikke den er helt gal på den : The two companies plan to use Biontech's innovative mRNA technology platform to develop a new class of antibody therapeutics targeting solid tumors. BNT322 is designed to selectively destroy cancer cells by engaging the immune system in a highly specific manner

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #411

      Genmab Announces Appointment of Martine van Vugt to Chief Strategy Officer https://ir.genmab.com/news-releases/news-release-details/genmab-announces-appointment-martine-van-vugt-chief-strategy

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #412

        epcoritamab on the CHMP agenda this week to discuss responses received to Day 120 List of Questions

        1 Reply Last reply
        0
        • SEACOPS Offline
          SEACOPS Offline
          SEACOP
          wrote on sidst redigeret af
          #413

          Er der nogen naturlig arvtager (kronprins/prinsesse), som blot rager lidt op?

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #414

            JNJ, AbbVie,

            1 Reply Last reply
            0
            • StockBullS Offline
              StockBullS Offline
              StockBull
              wrote on sidst redigeret af
              #415

              Link Preview Image
              The M&A hunt is on — here are the prime targets

              Companies with advanced molecular therapies, oncology assets and obesity treatments could be fuel for a dealmaking fire this year.

              favicon

              PharmaVoice (www.pharmavoice.com)

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #416

                Sanofi proposed to acquire Provention Bio for $2,9B in cash at 273% premium.

                1 Reply Last reply
                0
                • royalR Offline
                  royalR Offline
                  royal
                  wrote on sidst redigeret af
                  #417

                  Har Abbvie råd til at købe Genmab?

                  1 Reply Last reply
                  0
                  • troldmandenT Offline
                    troldmandenT Offline
                    troldmanden
                    wrote on sidst redigeret af
                    #418

                    Tror ikke lige Amanda er så heldig med den "liste" over opkøbs kandidater. Altimmune har lige præsenteret data. Fint vægtab på ca 10%. Men "Most patients experienced nausea and vomiting of mild and moderate severity"

                    1 Reply Last reply
                    0
                    • StockBullS Offline
                      StockBullS Offline
                      StockBull
                      wrote on sidst redigeret af
                      #419

                      Ja, AbbVie (ABBV) står over for et af de stejleste patentfrafald i branchen, når Humira mister sin amerikanske eksklusivitet næste år. Analytikere forventer, at virksomheden vil have 69 milliarder dollars i frit cash flow frem til 2024 for at genopbygge sine hylder. Andre firmaer, der forventes at se høje kontanter, er Roche, Bristol Myers og Merck.

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #420

                        Pfizer

                        1 Reply Last reply
                        0
                        • StockBullS Offline
                          StockBullS Offline
                          StockBull
                          wrote on sidst redigeret af
                          #421

                          Humira Main patent expiring: 2023

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #422

                            Attention Required! | Cloudflare

                            favicon

                            (www.biostock.se)

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #423

                              Daratumumab Seen as Effective in Patients With Refractory Acquired Hemophilia A https://www.rarediseaseadvisor.com/news/hem-news-briefs/daratumumab-effective-refractory-acquired-hemophilia-a-immunosuppressants-fviii/

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #424

                                Godmorgen 🙂

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #425

                                  March 29, 2023 : Annual General Meeting 2023 https://www.proinvestor.com/investornyt/960870/march-29-2023-annual-general-meeting-2023

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Stroka
                                    wrote on sidst redigeret af
                                    #426

                                    God morgen 🙂

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #427

                                      Bank of America Securities analyst Sachin Jain maintained a Buy rating on Genmab (GMAB – Research Report) yesterday and set a price target of $48.00. https://markets.businessinsider.com/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-genmab-gmab-1032196485

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #428

                                        AGM starting

                                        1 Reply Last reply
                                        0
                                        • DarvinD Offline
                                          DarvinD Offline
                                          Darvin
                                          wrote on sidst redigeret af
                                          #429

                                          Thank you E L BofA hits exactly what we're aiming for, so far! Converted, their target for the share price is DKK 3,002

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper